Recombinant Human MT2A Protein，His

MT2A (Metallothionein 2A) is a low-molecular-weight, cysteine-rich protein that plays a crucial role in metal ion homeostasis, detoxification, and cellular protection against oxidative stress. The MT2A gene is part of a larger metallothionein family that responds to various physiological and pathological stimuli, including heavy metal exposure, inflammation, and cellular stress. Research has shown that MT2A is implicated in numerous biological processes, such as cell proliferation, apoptosis, and differentiation. Its expression is tightly regulated and varies across different tissues and developmental stages, highlighting its significance in both normal physiology and disease contexts. Studies have linked altered MT2A expression to various health conditions, including cancer, neurodegenerative disorders, and cardiovascular diseases, suggesting that it may serve as a potential biomarker or therapeutic target. Given its multifunctional roles, recombinant MT2A protein has garnered attention for studying its specific functions in cellular mechanisms, understanding metal toxicity, and exploring its potential in biomedicine. The development of MT2A recombinant protein allows researchers to investigate its structural properties, binding affinities to metal ions, and interactions with other cellular proteins, thereby providing insights into its role in maintaining metal homeostasis and protecting cells from oxidative damage. As the field continues to explore the therapeutic implications of MT2A, understanding its molecular dynamics and regulatory pathways will be critical for advancing treatment strategies for metal-related disorders and promoting cellular health.